Medical cannabis with safety, efficacy and dignity
The only gum that turns cannabis into medicine: precise monodose, full spectrum, and European Pharmacopoeia validation (Ph. Eur. 2.9.25). THC, CBD or mixed formulations
The only gum that turns cannabis into medicine: precise monodose, full spectrum, and European Pharmacopoeia validation (Ph. Eur. 2.9.25). THC, CBD or mixed formulations
We have achieved a pharmaceutical milestone: the first medical cannabis gum that meets all European Pharmacopoeia standards, including the Ph. Eur. 2.9.25 dissolution test, validating a 70% release of the active ingredient in THC/CBD formulations.
Oils and sprays show variability in dosing.
Our gum guarantees pharmacopoeia-level uniformity in every dose.
Vaporizers degrade components and lose phytochemical profile.
Our gum preserves the full profile of cannabinoids, terpenes and flavonoids.
Other formats lack placebo option and GMP traceability.
Our gum is developed under GMP, with placebo and buccal mucosa absorption, reducing adverse effects.
We want to hear from you. If you are looking to collaborate, invest, or learn more about our technology, reach out and let’s talk.
Madrid, Spain · info@mfdevelopments.com
Precise monodose
Full spectrum
Pharmacological safety
≥70% release in 30 min
Inaccurate dosing and variable absorption.
Our gum ensures pharmacopoeia-validated uniformity in every dose
Thermal degradation and lack of reproducibility
Our gum preserves the full phytochemical profile with pharmaceutical precision
Low dosing accuracy and limited institutional acceptance.
Our gum provides pharmacological control and higher clinical safety
